Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
08/2012
08/09/2012US20120201751 Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
08/09/2012US20120201750 Serum biomarkers for melanoma metastasis
08/09/2012US20120201749 NP-1 Antagonists and Their Therapeutic Use
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012US20120201747 System and Method for Diagnosis and Treatment
08/09/2012US20120201746 Half immunoglobulin binding proteins and uses thereof
08/09/2012CA2826144A1 Foxc1 antibodies and methods of their use
08/08/2012EP2484386A1 Molecular probe for pancreatic islet imaging and use of said probe
08/08/2012EP2483315A2 Conjugates targeting the cd163 receptor
08/08/2012EP1622646B1 Treatment of lupus targeting the macrophages or the folate receptor
08/08/2012EP1127148B1 Variants of humanized anti-carcinoma monoclonal antibody cc49
08/08/2012CN102626522A Polypeptide radioactive diagnosis and treatment medicament based on chemotactic factor receptor CXCR4 polypeptide antagonist
08/08/2012CN102626399A Calcium alginate microcapsule, preparation method and application thereof
08/07/2012US8236770 Serum-stable amphoteric liposomes
08/07/2012US8236282 Benzothiazole derivative compounds, compositions and uses
08/07/2012US8236281 Pharmaceutical composition of nanoparticles
08/07/2012US8236280 Polyamides for nucleic acid delivery
08/07/2012US8236279 Bisaminoethanethiol-targeting ligand conjugates and compositions
08/07/2012CA2447367C Diagnosis and treatment of malignant neoplasms
08/02/2012WO2012102820A1 System for defining energy field characteristics to illuminate nano-particles used to treat invasive agents
08/02/2012WO2012102363A1 Drug delivery system and use of same
08/02/2012WO2012075241A3 Protease degradable polypeptides and uses thereof
08/02/2012US20120195832 Process for producing an injectable medicament preparation
08/02/2012US20120195831 Generation, characterization and uses thereof of anti-her3 antibodies
08/02/2012US20120195830 Monoclonal Antibodies Against Claudin-18 For Treatment of Cancer
08/02/2012US20120195829 Methods for identifying targeting domains and method and compositions comprising the same
08/02/2012US20120195828 Kidney-imaging agent comprising recombinant gelatin
08/02/2012US20120195827 Myocardial perfusion imaging methods and compositions
08/02/2012US20120195826 Injectable biomaterial
08/01/2012EP2480258A1 Chemical production module and dose synthesis card for pet biomarker production system
08/01/2012EP2480257A2 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/01/2012EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
08/01/2012CN102617728A 18F labeled product of Exendin-4, preparation process and application thereof
08/01/2012CN102617556A Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
08/01/2012CN102614536A Cell apoptosis imaging medicament 68Ga-NOTA-Duramycin and preparation method thereof
08/01/2012CN101501033B Novel compound having affinity for amyloid
07/2012
07/31/2012US8231859 Compositions for delivery of therapeutics and other materials
07/31/2012US8231858 Diagnostic imaging agents with MMP inhibitory activity
07/31/2012US8231530 Methods and systems for assessing gastric emptying
07/26/2012WO2012066498A4 Brachytherapy seed, methodology and calculating dose of brachytherapy and method of treatment
07/26/2012US20120190975 Nanoparticles for use in tumor diagnosis and therapy
07/26/2012US20120190560 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
07/26/2012US20120189548 2-arylpyrazolo[l,5-alpha]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda)
07/26/2012US20120189547 [18f] labelled analogues of flumazenil as in vivo imaging agents
07/26/2012US20120189546 Radiolabelling Method Using Cycloalkyl Groups
07/26/2012US20120189545 Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins
07/26/2012US20120189544 Gastrointestinal disease or disorder imaging and treatment
07/26/2012US20120189543 Compositions and Methods for Detecting and Treating Implant Loosening and Osteolysis
07/26/2012US20120189542 Anti-CD19 Antibodies
07/26/2012US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof
07/26/2012US20120189540 IL3Ralpha Antibody Conjugates And Uses Thereof
07/26/2012US20120189539 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
07/26/2012US20120189538 Use of a2a adenosine receptor agonists
07/26/2012US20120189537 Nitrile derivatives and their pharmaceutical use and compositions
07/25/2012EP2478110A1 Class i anti-cea antibodies and uses thereof
07/25/2012EP2477661A1 Selective detection of bone metastases in renal clear cell carcinoma
07/25/2012EP2131867B1 Modified hydroxypolymer conjugates with killing effect on tumor cells
07/25/2012EP1624901B1 Prosthetic groups attached to stannylated polymers for the synthesis of radiopharmaceuticals
07/25/2012EP1592457B1 Folate-vinblastine conjugate as medicament
07/25/2012CN102603894A Interferon alpha receptor 1 antibodies and their uses
07/25/2012CN102603647A 18/19F-ester nitroimidazole compound, preparation method thereof and application as hypoxic tissue developing agent
07/25/2012CN102600489A Peptide radioactive medicine comprising iRGD sequence
07/25/2012CN102600488A Imaging the central nervous system
07/25/2012CN102600487A Imaging the central nervous system
07/25/2012CN102060880B 99mTc(CO)3-DGDTC complex as well as preparation method and application thereof
07/25/2012CN101829341B Hydroxyapatite nanoparticle radionuclide marked product and preparation method thereof
07/25/2012CN101622342B Cancerous disease modifying antibodies
07/24/2012US8226929 Contrast agents for myocardial perfusion imaging
07/24/2012US8226928 Pharmaceutical composition of nanoparticles
07/24/2012US8226927 11C/18F-labeled inhibitors of glycogen synthase kinase-3
07/24/2012US8226926 Compositions and methods using microspheres and non-ionic contrast agents
07/24/2012CA2410887C Compounds for targeting endothelial cells, compositions containing the same and methods for their use
07/19/2012WO2012096760A1 Radiolabled her2 binding peptides
07/19/2012WO2012066006A3 Agents and methods for visualising analytes
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183474 Methods and System for Detecting Soluble Amyloid-Beta
07/19/2012US20120183473 Active ingredient and method for testing an active ingredient
07/19/2012US20120183472 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
07/19/2012US20120183471 Specific binding proteins and uses thereof
07/19/2012CA2822693A1 Radiolabled her2 binding peptides
07/18/2012EP2475400A2 Non-radioactive phospholipid compounds, compositions, and methods of use
07/18/2012EP2475399A1 Methods for diagnosis and intervention of hepatic disorders
07/18/2012EP2475363A1 Detection of mycobacteria
07/18/2012CN102596260A Zirconium-radiolabeled, cysteine engineered antibody conjugates
07/18/2012CN102596259A Molecular probe for pancreatic islet imaging and use of said probe
07/18/2012CN102596258A Methods for generating radioimmunoconjugates
07/18/2012CN102585202A Dendritic polyglycerol sulfates and sulfonates and their use for inflammatory diseases
07/18/2012CN102584774A Xanthenone derivative and application thereof
07/18/2012CN101628910B Novel micromolecule compound having high affinity with Abeta plaque as well as synthesis and application thereof
07/18/2012CN101563108B Radiolabelled peptide based compounds and uses thereof
07/18/2012CN101024657B Metronidazole phosphate complex with 99m Tc mark and its preparing method
07/17/2012US8222398 Chimeric immunomodulatory compounds and methods of using the same-II
07/17/2012US8221759 Neutralizing monoclonal antibodies to respiratory syncytial virus
07/17/2012US8221757 Monoclonal antibodies against extracellular loops of C5aR
07/17/2012US8221751 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof
07/17/2012US8221720 Purification methods
07/17/2012US8221719 Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof
07/17/2012CA2542049C Finely particulate composite containing carbon compound encapsulated therein
07/12/2012WO2012094034A1 Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure
07/12/2012US20120178820 Method for treating arthritis
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 243